09.06.2022 - BioVersys announces successful first closing of CHF 24.2 million Series C financing to develop clinical pipeline of novel AMR therapies
startuplaw.ch
Excellence in execution and teamwork – we know the needs of entrepreneurs.
Events
There are currently no events planned.